WELCOME TO NEURIX
There are currently more than 600 diseases characterized as affecting the central nervous system which inflict neural damage. Unfortunately, few of these conditions have effective treatments available. Neurix is committed to pursue innovation and breakthrough technologies to disrupt the negative trend.
NEWS, EVENTS & INNOVATIONS
Learn more about our Coronavirus in vitro tools
The spike fusion assay for the specific detection of neutralizing antibodies, in vitro tools for drug screening as well as personalized services.
Transcend consortium for Parkinon's disease model
Neurix develops a microglia-embedded cerebral organoid model of Parkinson's disease, in collaboration with Innoser and the University of Geneva
WE KEEP YOU UPDATED
You want to hear about the last advances of our technology ? Please provide us you contact details to keep you updated. (not efficient on firefox browser)
3-DIMENSIONAL NEURAL TISSUE
Neurix provides services for drug discovery and development. We generate physiologically relevant 3-dimensional neural tissues derived from human pluripotent stem cells. Our organoids display accelerated cell maturity that mimic the native brain tissue. Predictive, accurate and reproducible, our in vitro human cell-based services enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.
We generate two formats of neural organoids to ensure compatibility with high troughtput screening, and optimal disease modeling services
- Full genomic / proteomic analysis
- High throughput compatible
BlastomaBrain Glioblastoma invasion model
Glioblastoma invading neural organoids to asses drug efficiency on tumor growth, motility and metastasis.
VirionBrain Gene therapy testing
Virus invasion model
Assessing the efficiency for gene therapies and anti-viral drug compounds.
CellBrain Cell therapy testing
Biomaterial therapy testing
Testing the efficiency of cell therapy, cell survival and integration inside the neural tissue
Neurix offers drug discovery services and personalized development of in vitro disease models, assays, and in dept -omic analyses.